How often should a child's drooling be reviewed after dose titration with glycopyrronium bromide 1 mg/5 ml oral solution (the Aspire Pharma Ltd product)?

After dose titration with glycopyrronium bromide 1 mg/5 ml oral solution (the Aspire Pharma Ltd product), the child's drooling should be reviewed with the carer at intervals no longer than three months to assess changes in efficacy and/or tolerability and adjust the dose accordingly.